Be a Part of the Next Flu Vaccine Breakthrough
Participate in Influenza mRNA Vaccine Clinical Trials!
Today’s flu vaccines undergo updates every year to prevent infection with the specific strains of the flu that scientists expect to be common that year. It takes several months to develop vaccines that are effective against the strain of virus that may be circulating.
However recent advances in mRNA technology are proving to be helpful to scientists and researchers. This helps them develop new vaccines that take less time to produce and maybe a better match to most common flu strains. Revival Research Institute is conducting Influenza mRNA Vaccine Clinical Trials to study the safety and efficacy of this investigational product that could potentially help the body produce antibodies that might fight off the flu.
You may be eligible for the Influenza mRNA Vaccine Clinical Trials if you:
- Are at least 65 years of age
- Have stable chronic conditions or are healthy
- Have not received an investigational or licensed flu vaccine in the last 6 months
- Additional criteria may apply
We are conducting a Phase 3 mRNA Flu Vaccine Study. This could be the breakthrough we need to fight against flu and other infectious diseases.
*To participate in the Influenza mRNA Vaccine Clinical Trials, please fill out the form, and someone from our research team will give you a call.
**The study vaccine and study-related care will be provided at no cost. If you decide to participate, there is no requirement for insurance.